Stephen Betz
Founder at CRINETICS PHARMACEUTICALS, INC.
Net worth: 4 M $ as of 31/03/2024
Profile
Stephen F.
Betz is the founder.
He founded Crinetics Pharmaceuticals, Inc. in 2008 and currently holds the title of Chief Scientific Officer.
He previously worked at Neurocrine Biosciences, Inc. from 2003 to 2009, where he held the position of Director-Endocrinology & Metabolism.
Before that, he worked at GeneFormatics, Inc. from 2001 to 2003 as the Head-Laboratory Efforts.
Mr. Betz completed his undergraduate degree at the University of Delaware in 1987.
He then went on to earn his doctorate degree from The University of North Carolina at Chapel Hill in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/03/2024 | 92,643 ( 0.12% ) | 4 M $ | 31/03/2024 |
Stephen Betz active positions
| Companies | Position | Start |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Founder | 01/01/2008 |
Former positions of Stephen Betz
| Companies | Position | End |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2009 |
| GeneFormatics, Inc. | Corporate Officer/Principal | 01/01/2003 |
Training of Stephen Betz
| University of Delaware | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| GeneFormatics, Inc. | Health Technology |
- Stock Market
- Insiders
- Stephen Betz
